267 related articles for article (PubMed ID: 9550389)
1. Effects of CD28 costimulation on long-term proliferation of CD4+ T cells in the absence of exogenous feeder cells.
Levine BL; Bernstein WB; Connors M; Craighead N; Lindsten T; Thompson CB; June CH
J Immunol; 1997 Dec; 159(12):5921-30. PubMed ID: 9550389
[TBL] [Abstract][Full Text] [Related]
2. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy.
Chen HW; Liao CH; Ying C; Chang CJ; Lin CM
Clin Immunol; 2006 Apr; 119(1):21-31. PubMed ID: 16406844
[TBL] [Abstract][Full Text] [Related]
3. TCR-independent activation of human CD4+ 45RO- T cells by anti-CD28 plus IL-2: Induction of clonal expansion and priming for a Th2 phenotype.
Brinkmann V; Kinzel B; Kristofic C
J Immunol; 1996 Jun; 156(11):4100-6. PubMed ID: 8666775
[TBL] [Abstract][Full Text] [Related]
4. The CD2 and CD28 adhesion molecules induce long-term autocrine proliferation of CD4+ T cells.
Costello R; Cerdan C; Pavon C; Brailly H; Hurpin C; Mawas C; Olive D
Eur J Immunol; 1993 Mar; 23(3):608-13. PubMed ID: 8095456
[TBL] [Abstract][Full Text] [Related]
5. CD28 is an inducible T cell surface antigen that transduces a proliferative signal in CD3+ mature thymocytes.
Turka LA; Ledbetter JA; Lee K; June CH; Thompson CB
J Immunol; 1990 Mar; 144(5):1646-53. PubMed ID: 2155264
[TBL] [Abstract][Full Text] [Related]
6. A humanised therapeutic CD4 mAb inhibits TCR-induced IL-2, IL-4, and IL-10 secretion and expression of CD25, CD40L, and CD69.
Woods M; Guy R; Waldmann H; Glennie M; Alexander DR
Cell Immunol; 1998 May; 185(2):101-13. PubMed ID: 9636688
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic and functional modulation of interleukin-2-activated peripheral blood mononuclear cells by anti-CD3 and anti-CD28 antibody.
Yoshino I; Yano T; Miyamoto M; Sugimachi K; Kimura G; Nomoto K
Lymphokine Cytokine Res; 1993 Aug; 12(4):191-6. PubMed ID: 8218591
[TBL] [Abstract][Full Text] [Related]
8. Antibody-induced CD3-CD4 coligation inhibits TCR/CD3 activation in the absence of costimulatory signals in normal mouse CD4(+) T lymphocytes.
Portolés P; de Ojeda G; Criado G; Fernández-Centeno E; Rojo JM
Cell Immunol; 1999 Aug; 195(2):96-109. PubMed ID: 10448009
[TBL] [Abstract][Full Text] [Related]
9. Deficient CD4+ T cell proliferation in the class 1 MHC-restricted 2C TCR-transgenic mouse.
Chen FL; Kung JT
J Immunol; 1996 Mar; 156(6):2036-44. PubMed ID: 8690890
[TBL] [Abstract][Full Text] [Related]
10. Anti-CD28-induced co-stimulation and TCR avidity regulates the differential effect of TGF-beta1 on CD4+ and CD8+ naïve human T-cells.
Gunnlaugsdottir B; Maggadottir SM; Ludviksson BR
Int Immunol; 2005 Jan; 17(1):35-44. PubMed ID: 15557315
[TBL] [Abstract][Full Text] [Related]
11. The capacity of the natural ligands for CD28 to drive IL-4 expression in naïve and antigen-primed CD4+ and CD8+ T cells.
Bian Y; Hiraoka S; Tomura M; Zhou XY; Yashiro-Ohtani Y; Mori Y; Shimizu J; Ono S; Dunussi-Joannopoulos K; Wolf S; Fujiwara H
Int Immunol; 2005 Jan; 17(1):73-83. PubMed ID: 15569772
[TBL] [Abstract][Full Text] [Related]
12. IL-2-induced IL-9 production by allergen-specific human helper T-cell clones.
Kajiyama Y; Umezu-Goto M; Kobayashi N; Takahashi K; Fukuchi Y; Mori A
Int Arch Allergy Immunol; 2007; 143 Suppl 1():71-5. PubMed ID: 17541281
[TBL] [Abstract][Full Text] [Related]
13. Effect of interleukin-15 on effector and regulatory function of anti-CD3/anti-CD28-stimulated CD4(+) T cells.
Lin SJ; Cheng PJ; Hsiao SS
Bone Marrow Transplant; 2006 May; 37(9):881-7. PubMed ID: 16565741
[TBL] [Abstract][Full Text] [Related]
14. Flow cytometric single-cell analysis of cytokine production by CD4+ T cells in synovial tissue and peripheral blood from patients with rheumatoid arthritis.
Morita Y; Yamamura M; Kawashima M; Harada S; Tsuji K; Shibuya K; Maruyama K; Makino H
Arthritis Rheum; 1998 Sep; 41(9):1669-76. PubMed ID: 9751101
[TBL] [Abstract][Full Text] [Related]
15. Crosslinking of CD27 in the presence of CD28 costimulation results in T cell proliferation and cytokine production.
Sunder-Plassmann R; Pickl WF; Majdic O; Knapp W; Holter W
Cell Immunol; 1995 Aug; 164(1):20-7. PubMed ID: 7634349
[TBL] [Abstract][Full Text] [Related]
16. Costimulatory signals modulate the antiproliferative effects of agents that elevate cAMP in T cells.
Bartik MM; Bauman GP; Brooks WH; Roszman TL
Cell Immunol; 1994 Oct; 158(1):116-30. PubMed ID: 8087859
[TBL] [Abstract][Full Text] [Related]
17. Expanded tumor-reactive CD4+ T-cell responses to human cancers induced by secondary anti-CD3/anti-CD28 activation.
Li Q; Furman SA; Bradford CR; Chang AE
Clin Cancer Res; 1999 Feb; 5(2):461-9. PubMed ID: 10037198
[TBL] [Abstract][Full Text] [Related]
18. CD3-CD28 costimulation as a means to avoiding T cell preactivation in bispecific monoclonal antibody-based treatment of ovarian carcinoma.
Mazzoni A; Mezzanzanica D; Jung G; Wolf H; Colnaghi MI; Canevari S
Cancer Res; 1996 Dec; 56(23):5443-9. PubMed ID: 8968099
[TBL] [Abstract][Full Text] [Related]
19. T-cell activation by recombinant receptors: CD28 costimulation is required for interleukin 2 secretion and receptor-mediated T-cell proliferation but does not affect receptor-mediated target cell lysis.
Hombach A; Sent D; Schneider C; Heuser C; Koch D; Pohl C; Seliger B; Abken H
Cancer Res; 2001 Mar; 61(5):1976-82. PubMed ID: 11280755
[TBL] [Abstract][Full Text] [Related]
20. CD28 co-stimulation regulates the effect of transforming growth factor-beta1 on the proliferation of naïve CD4+ T cells.
Sung JL; Lin JT; Gorham JD
Int Immunopharmacol; 2003 Feb; 3(2):233-45. PubMed ID: 12586604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
